WallStreetZenWallStreetZen

NASDAQ: LABT
Lakewood Amedex Biotherapeutics Inc Stock Ownership - Who owns Lakewood Amedex Biotherapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lakewood Amedex Biotherapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LABT insiders and whales buy or sell their stock.

LABT Shareholders

What type of owners hold Lakewood Amedex Biotherapeutics Inc stock?

No data
There are no institutional or insider shareholders.

LABT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AAPG0.01%22.93%
AARD49.26%46.87%Net Buying
ABUS30.49%69.51%
ABVC3.36%82.65%
ABVX71.68%0.00%
View Top Biotech Stocks

Lakewood Amedex Biotherapeutics Stock Ownership FAQ

Who owns Lakewood Amedex Biotherapeutics?

Lakewood Amedex Biotherapeutics (NASDAQ: LABT) is owned by 0.00% institutional shareholders, 0.00% Lakewood Amedex Biotherapeutics insiders, and 100.00% retail investors.

If you're new to stock investing, here's how to buy Lakewood Amedex Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.